News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Insights from the ESTRO Lower GI Course
ESTRO/LinkedIn
Apr 15, 2025, 09:54

Insights from the ESTRO Lower GI Course

European Society for Radiotherapy and Oncology (ESTRO) posted on LinkedIn:

“Insights from the ESTRO Lower GI Course: How do recent developments in rectal and anal cancer treatment shape clinical practice?

The ESTRO Lower GI Course provided key updates on organ preservation, patient selection, and treatment personalization, with expert discussions and hands-on learning.”

Read Further.

cancer ESTRO ESTRO Lower GI Course OncoDaily Oncology
Special Coverage
Blog
May 30, 2025, 06:50
Cecilia Pompili: Grateful to Join the ESTS25 Thoracic Surgery in LMICs Session
Blog
May 30, 2025, 06:43
Aakash Desai: Will you be at ASCO25?
Blog
May 30, 2025, 06:35
Jay Bradner: Molecular Determinants of Sotorasib Clinical Efficacy in KRASG12C-NSCLC
Blog
May 30, 2025, 06:25
Leonidas Platanias Announces “Exceptional” NCI Rating for Lurie Cancer Center
Blog
May 30, 2025, 06:09
Roberto Borea: Liquid Biopsy in the spotlight at ASCO25
Blog
May 30, 2025, 06:00
Hem-Onc Fellows Network Highlights ASCO 2025 Session on Visibility and Achievement for Trainees
Blog
May 30, 2025, 05:52
C. Jillian Tsai: Phase II Study of Pembrolizumab and Chemoradiation in Head and Neck Cancer
Blog
May 30, 2025, 05:42
Colorectal Cancer Alliance and PeerView Live at ASCO 2025 on Systemic Therapy Regimens in CRC
Blog
May 30, 2025, 05:33
IPOS - Fear of Cancer Recurrence Special Interest Group (FORwards) presents Meet the Expert
Blog
May 30, 2025, 01:27
$225,000 AACR Gertrude B. Elion Award Supports Junior Faculty Cancer Research - AACR
Blog
May 30, 2025, 01:15
Lung cancer is now the leading cause of cancer death among women worldwide - UICC
Blog
May 30, 2025, 01:04
Monica Kraft: New Evidence Supports As-Needed Albuterol and Budesonide for Mild Asthma